Christina Nguyen Deane, OD
Optometry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 7 carriers
- Office
- 1
Offices
1 location · Bdhv Medical Group of California PC · 5 clinicians in this group
Looking this up.
Plans that list them
24 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Deane’s office at (408) 869-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$55,973
Medicare paid this office $55,973 for 430 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 234 | $27,112 | $113 |
| Short return visit (20+ min) | 101 | $9,332 | $76 |
| Established patient problem focused exam of visual system | 75 | $7,118 | $89 |
| New patient complete exam of visual system | 29 | $3,632 | $125 |
| Return visit (30+ min) | 37 | $3,278 | $89 |
See all 7 services
| Established patient complete exam of visual system | 234 | $27,112 | $113 |
| Short return visit (20+ min) | 101 | $9,332 | $76 |
| Established patient problem focused exam of visual system | 75 | $7,118 | $89 |
| New patient complete exam of visual system | 29 | $3,632 | $125 |
| Return visit (30+ min) | 37 | $3,278 | $89 |
| Imaging of retina | 38 | $1,285 | $34 |
| Imaging of optic nerve | 21 | $720 | $31 |
Who their Medicare patients are
430 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 21% · Women 63% · Also on Medicaid 11% · Health risk score 1.08. Above the middle of the specialty; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 73% · Diabetes 27% · Coronary heart disease 25% · Chronic kidney disease 21% · Cancer 18% · Atrial fibrillation 17% · Depression 16% · Heart failure 12% · Stroke 9% · COPD 8% · Dementia 6%.
The office billed $127,778, Medicare allowed $81,082 and paid $55,973; for 632 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 430 | 632 | 77 | 1.08 | $127,778 | $55,973 |
| 2023 | 301 | 423 | 76 | 1.03 | $83,103 | $34,901 |
| 2022 | 157 | 225 | 77 | 1.00 | $44,048 | $18,382 |
| 2021 | 130 | 179 | 77 | 0.82 | $33,159 | $14,499 |
| 2020 | 148 | 212 | 77 | 1.07 | $42,557 | $16,527 |
| 2019 | 121 | 179 | 75 | 1.18 | $35,443 | $14,379 |
| 2018 | 68 | 83 | 77 | 1.01 | $17,053 | $5,844 |
| 2017 | 51 | 66 | 78 | 1.24 | $13,226 | $4,361 |
| 2016 | 43 | 50 | 80 | 1.16 | $10,547 | $3,451 |
| 2015 | 22 | 30 | 81 | 1.27 | $5,528 | $1,618 |
| 2014 | 22 | 26 | 76 | 0.92 | $4,730 | $1,479 |
| 2013 | 30 | 41 | 81 | 1.21 | $7,498 | $2,636 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Established patient complete exam of visual system | 111 | $11,382 | $103 |
| Short return visit (20+ min) | 83 | $8,037 | $82 |
| Established patient problem focused exam of visual system | 42 | $3,835 | $89 |
| New patient complete exam of visual system | 31 | $3,663 | $118 |
| Return visit (30+ min) | 27 | $3,125 | $98 |
| Imaging of optic nerve | 20 | $625 | $31 |
| Exam of visual field with extended testing | 11 | $585 | $53 |
| Imaging of retina | 16 | $580 | $36 |
2022: 5 services
| Established patient complete exam of visual system | 60 | $5,490 | $91 |
| Short return visit (20+ min) | 44 | $4,565 | $83 |
| Return visit (30+ min) | 16 | $2,205 | $116 |
| Short return visit | 22 | $1,297 | $48 |
| Imaging of optic nerve | 13 | $363 | $28 |
2021: 4 services
| Established patient complete exam of visual system | 64 | $7,105 | $111 |
| Short return visit (20+ min) | 29 | $3,171 | $86 |
| Short return visit | 20 | $1,024 | $47 |
| Imaging of optic nerve | 15 | $516 | $34 |
2020: 6 services
| Established patient complete exam of visual system | 63 | $6,892 | $106 |
| Short return visit (20+ min) | 45 | $3,634 | $70 |
| Return visit (30+ min) | 17 | $1,367 | $76 |
| New patient complete exam of visual system | 12 | $1,347 | $112 |
| Exam of visual field with extended testing | 11 | $702 | $64 |
| Imaging of optic nerve | 13 | $442 | $34 |
2019: 4 services
| Short return visit (20+ min) | 41 | $4,062 | $69 |
| Established patient complete exam of visual system | 32 | $3,605 | $113 |
| Return visit (30+ min) | 25 | $2,849 | $98 |
| New patient complete exam of visual system | 17 | $1,913 | $113 |
2018: 3 services
| Short return visit (20+ min) | 19 | $1,489 | $57 |
| Established patient complete exam of visual system | 12 | $1,330 | $102 |
| Ultrasound scan to determine eye length and lens power | 18 | $1,222 | $68 |
2017: 2 services
| Short return visit (20+ min) | 18 | $1,170 | $56 |
| New patient complete exam of visual system | 13 | $1,149 | $88 |
2016: 1 service
| Ultrasound scan to determine eye length and lens power | 26 | $1,956 | $75 |
2014: 1 service
| Short return visit (20+ min) | 14 | $792 | $57 |
2013: 1 service
| Short return visit (20+ min) | 17 | $1,215 | $64 |
Drugs they prescribed that Part D paid
$24,501
Pharmacies billed $24,501 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 149) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
87 generic and 62 brand-name prescriptions · $24,501 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cequa | 13 | $10,640 | $818 |
| Restasis | 15 | $7,256 | $484 |
| Erythromycin | 30 | $333 | $11 |
| Latanoprost | 17 | $219 | $13 |
| Neomycin-Polymyxin-Dexameth | 14 | $167 | $12 |
Year by year
| 2024 | 149 | 84 | 0% (0) | 42% | $24,501 |
| 2023 | 59 | 41 | 0% (0) | 36% | $7,676 |
| 2022 | 26 | 19 | 0% (0) | None | $635 |
| 2021 | 29 | 18 | 0% (0) | 38% | $1,805 |
| 2020 | 29 | 13 | 0% (0) | 72% | $9,491 |
| 2019 | 19 | 16 | 0% (0) | None | $3,508 |
| 2018 | 13 | None | 0% (0) | None | $294 |
| 2017 | 13 | None | 0% (0) | None | $929 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Erythromycin | 13 | $131 | $10 |
2020: 1 drug
| Cequa | 13 | $8,318 | $640 |
Money from drug and device companies
$239 in 2025
| 2025 | 6 | 10 | None | $239 |
| 2024 | 5 | 6 | None | $121 |
| 2023 | 9 | 14 | None | $662 |
| 2022 | 10 | 15 | None | $296 |
| 2021 | 9 | 12 | None | $209 |
| 2020 | 4 | 18 | None | $206 |
| 2019 | 5 | 30 | None | $516 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Tryptyr | $76 | 3 payments
|
| Amgen | Tepezza | $46 | 2 payments
|
| Bausch & Lomb Americas | Vyzulta | $33 | 2 payments
|
| Dompe US | Oxervate | $32 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $31 | 1 payment
|
| Abbvie | Lumigan | $21 | 1 payment
|
See all 10 published payments
| Amgen | Meals · 2025-12-04 | Tepezza | $24 |
| Alcon Vision | Meals · 2025-11-06 | Precision7 | $25 |
| Sun Pharmaceutical Industries | Meals · 2025-11-04 | Cequa | $31 |
| Abbvie | Meals · 2025-10-17 | Lumigan | $21 |
| Dompe US | Meals · 2025-09-04 | Oxervate | $32 |
| Alcon Vision | Meals · 2025-08-28 | Tryptyr | $33 |
| Bausch & Lomb Americas | Meals · 2025-08-28 | Miebo | $14 |
| Alcon Vision | Meals · 2025-07-26 | Tryptyr | $17 |
| Bausch & Lomb Americas | Meals · 2025-04-14 | Vyzulta | $19 |
| Amgen | Meals · 2025-03-26 | Tepezza | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $121
| Bausch & Lomb Americas | Vyzulta | $44 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $23 | 1 payment
|
| Amgen | Tepezza | $20 | 1 payment
|
| Alcon Vision | Clareon | $20 | 1 payment
|
| CooperVision | Myday Contact Lens | $14 | 1 payment
|
2023: $662
| Biotissue Holdings | Prokera | $173 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $164 | 3 payments
|
| Bausch & Lomb Americas | Miebo | $132 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $65 | 2 payments
|
| Apellis Pharmaceuticals | None | $34 | 1 payment
|
| Astellas Pharma US | None | $33 | 1 payment
|
| Sight Sciences | Tearcare System | $26 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $20 | 1 payment
|
| Alcon Vision | Precision 1 | $15 | 1 payment
|
2022: $296
| Kala Pharmaceuticals | Inveltys | $58 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $45 | 2 payments
|
| Alcon Vision | Rhopressa | $43 | 2 payments
|
| Sight Sciences | Tearcare Smartlid | $39 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $23 | 1 payment
|
| Abbvie | Vuity | $23 | 1 payment
|
| Allergan | Vuity | $22 | 1 payment
|
| BioTissue Holdings | Prokera | $18 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $14 | 1 payment
|
| CooperVision | Myday Contact Lens | $12 | 1 payment
|
2021: $209
| Novartis Pharmaceuticals | Xiidra | $40 | 2 payments
|
| Kala Pharmaceuticals | Inveltys | $34 | 2 payments
|
| Aerie Pharmaceuticals | Rocklatan | $31 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Infuse | $23 | 1 payment
|
| TearLab | Tearlab Osmolarity System | $19 | 1 payment
|
| Johnson & Johnson Vision Care | Acuvue | $18 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $17 | 1 payment
|
| Allergan | Durysta | $14 | 1 payment
|
| Dompe US | Oxervate | $14 | 1 payment
|
2020: $206
| Sun Pharmaceutical Industries | Cequa | $115 | 13 payments
|
| Aerie Pharmaceuticals | Rhopressa | $68 | 3 payments
|
| Johnson & Johnson Vision Care | Acuvue | $17 | 1 payment
|
| TissueTech | Prokera | $5 | 1 payment
|
2019: $516
| Sun Pharmaceutical Industries | Cequa | $277 | 14 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $146 | 11 payments
|
| Aerie Pharmaceuticals | Rhopressa | $58 | 3 payments
|
| Kala Pharmaceuticals | Inveltys | $19 | 1 payment
|
| Sight Sciences | Tearcare | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 92.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1891796629
- Licence
- CA OPT10150T
- Trained
- Indiana University - School of Optometry, 1991
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 220 Meridian Ave, San Jose, CA, 95126
- NPI first listed
- 2005-08-02
- NPI last updated
- 2020-04-29
- NPI record certified
- 2020-04-29
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.